Hostname: page-component-586b7cd67f-r5fsc Total loading time: 0 Render date: 2024-11-25T11:11:53.757Z Has data issue: false hasContentIssue false

Beyond the Dopamine Hypothesis to the NMDA Glutamate Receptor Hypofunction Hypothesis of Schizophrenia

Published online by Cambridge University Press:  07 November 2014

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Trends in Psychopharmacology
Copyright
Copyright © Cambridge University Press 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1.Meltzer, HY, Stahl, SM. The dopamine hypothesis of schizophrenia: a review. Schizophr Bull. 1976;2:1976.CrossRefGoogle ScholarPubMed
2.Stahl, SM. Essential Psychopharmacology 3rd ed. New York, NY: Cambridge University Press. In press.Google Scholar
3.Jentsch, JD, Roth, RH. The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology. 1999;20:201225.CrossRefGoogle Scholar
4.Javitt, DC, Zukin, SR. Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry. 1991;148:13011308.Google ScholarPubMed
5.Tamminga, CA, Holcomb, HH, Gao, XM, Lahti, AC. Glutamate pharmacology and the treatment of schizophrenia: current status and future directions. Int Clin Psychopharmacol. 1995;3:2937.Google Scholar
6.Goff, DC, Coyle, RJ. The emerging role of glutamate in the pathophysiology and treatment of schizophrenia. Am J Psychiatry. 2001;158:13671368.CrossRefGoogle ScholarPubMed
7.Straub, RE, Weinberger, DR. Schizophrenia genes: from famine to feast. Biol Psychiatry. 2006;60:8183.CrossRefGoogle ScholarPubMed